• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

差异甲基化 CpG 位点对乳腺癌靶长链非编码 RNA 染色质结构的影响。

Effects of Differentially Methylated CpG Sites in Enhancer and Promoter Regions on the Chromatin Structures of Target LncRNAs in Breast Cancer.

机构信息

School of Physical Science and Technology, Inner Mongolia University, Hohhot 010021, China.

The State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, Inner Mongolia University, Hohhot 010021, China.

出版信息

Int J Mol Sci. 2024 Oct 15;25(20):11048. doi: 10.3390/ijms252011048.

DOI:10.3390/ijms252011048
PMID:39456830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11507307/
Abstract

Aberrant DNA methylation plays a crucial role in breast cancer progression by regulating gene expression. However, the regulatory pattern of DNA methylation in long noncoding RNAs (lncRNAs) for breast cancer remains unclear. In this study, we integrated gene expression, DNA methylation, and clinical data from breast cancer patients included in The Cancer Genome Atlas (TCGA) database. We examined DNA methylation distribution across various lncRNA categories, revealing distinct methylation characteristics. Through genome-wide correlation analysis, we identified the CpG sites located in lncRNAs and the distally associated CpG sites of lncRNAs. Functional genome enrichment analysis, conducted through the integration of ENCODE ChIP-seq data, revealed that differentially methylated CpG sites (DMCs) in lncRNAs were mostly located in promoter regions, while distally associated DMCs primarily acted on enhancer regions. By integrating Hi-C data, we found that DMCs in enhancer and promoter regions were closely associated with the changes in three-dimensional chromatin structures by affecting the formation of enhancer-promoter loops. Furthermore, through Cox regression analysis and three machine learning models, we identified 11 key methylation-driven lncRNAs (DIO3OS, ELOVL2-AS1, MIAT, LINC00536, C9orf163, AC105398.1, LINC02178, MILIP, HID1-AS1, KCNH1-IT1, and TMEM220-AS1) that were associated with the survival of breast cancer patients and constructed a prognostic risk scoring model, which demonstrated strong prognostic performance. These findings enhance our understanding of DNA methylation's role in lncRNA regulation in breast cancer and provide potential biomarkers for diagnosis.

摘要

异常的 DNA 甲基化通过调控基因表达在乳腺癌的进展中起着至关重要的作用。然而,乳腺癌中长链非编码 RNA(lncRNA)的 DNA 甲基化调控模式尚不清楚。在这项研究中,我们整合了来自癌症基因组图谱(TCGA)数据库中包含的乳腺癌患者的基因表达、DNA 甲基化和临床数据。我们检查了各种 lncRNA 类别中的 DNA 甲基化分布,揭示了不同的甲基化特征。通过全基因组相关性分析,我们确定了位于 lncRNA 中的 CpG 位点和 lncRNA 的远端相关 CpG 位点。通过整合 ENCODE ChIP-seq 数据进行的功能基因组富集分析表明,lncRNA 中差异甲基化的 CpG 位点(DMCs)主要位于启动子区域,而远端相关的 DMCs 主要作用于增强子区域。通过整合 Hi-C 数据,我们发现增强子和启动子区域中的 DMCs 通过影响增强子-启动子环的形成,与三维染色质结构变化密切相关。此外,通过 Cox 回归分析和三种机器学习模型,我们确定了 11 个关键的甲基化驱动的 lncRNA(DIO3OS、ELOVL2-AS1、MIAT、LINC00536、C9orf163、AC105398.1、LINC02178、MILIP、HID1-AS1、KCNH1-IT1 和 TMEM220-AS1),它们与乳腺癌患者的生存相关,并构建了一个预后风险评分模型,该模型表现出了强大的预后性能。这些发现增强了我们对 DNA 甲基化在乳腺癌中 lncRNA 调控中的作用的理解,并为诊断提供了潜在的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/8b271b429e7d/ijms-25-11048-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/e6187407bb20/ijms-25-11048-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/aafa846571cc/ijms-25-11048-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/b2f36ca424ff/ijms-25-11048-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/f2e4c02b0910/ijms-25-11048-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/d1f182e226be/ijms-25-11048-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/ee6585f8c092/ijms-25-11048-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/9ee52d29ff4f/ijms-25-11048-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/8b271b429e7d/ijms-25-11048-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/e6187407bb20/ijms-25-11048-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/aafa846571cc/ijms-25-11048-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/b2f36ca424ff/ijms-25-11048-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/f2e4c02b0910/ijms-25-11048-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/d1f182e226be/ijms-25-11048-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/ee6585f8c092/ijms-25-11048-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/9ee52d29ff4f/ijms-25-11048-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a13/11507307/8b271b429e7d/ijms-25-11048-g008.jpg

相似文献

1
Effects of Differentially Methylated CpG Sites in Enhancer and Promoter Regions on the Chromatin Structures of Target LncRNAs in Breast Cancer.差异甲基化 CpG 位点对乳腺癌靶长链非编码 RNA 染色质结构的影响。
Int J Mol Sci. 2024 Oct 15;25(20):11048. doi: 10.3390/ijms252011048.
2
Genome-wide methylome and chromatin interactome identify abnormal enhancer to be risk factor of breast cancer.全基因组甲基化组和染色质相互作用组确定异常增强子为乳腺癌的危险因素。
Oncotarget. 2017 Jul 4;8(27):44705-44719. doi: 10.18632/oncotarget.18348.
3
Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer.全基因组差异甲基化长链非编码RNA筛选鉴定出Esrp2和lncRNA Esrp2-as受增强子DNA甲基化调控,与人类乳腺癌预后相关。
Oncogene. 2017 Nov 16;36(46):6446-6461. doi: 10.1038/onc.2017.246. Epub 2017 Jul 31.
4
Computational epigenetic landscape analysis reveals association of CACNA1G-AS1, F11-AS1, NNT-AS1, and MSC-AS1 lncRNAs in prostate cancer progression through aberrant methylation.计算表观遗传景观分析揭示 CACNA1G-AS1、F11-AS1、NNT-AS1 和 MSC-AS1 lncRNAs 通过异常甲基化在前列腺癌进展中的关联。
Sci Rep. 2022 Jun 17;12(1):10260. doi: 10.1038/s41598-022-13381-0.
5
LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.长链非编码 RNA DSCAM-AS1 通过与 YBX1 相互作用形成正反馈环,激活 FOXA1 转录网络,从而促进癌症进展。
Theranostics. 2020 Aug 29;10(23):10823-10837. doi: 10.7150/thno.47830. eCollection 2020.
6
Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.lncRNA SOX21-AS1 的低甲基化在宫颈癌中具有临床预后价值。
Life Sci. 2019 Sep 15;233:116708. doi: 10.1016/j.lfs.2019.116708. Epub 2019 Jul 29.
7
Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer.顺式作用超级增强子长非编码 RNA 作为早期乳腺癌的生物标志物。
Breast Cancer Res. 2021 Oct 30;23(1):101. doi: 10.1186/s13058-021-01479-8.
8
Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.系统分析 lncRNA-miRNA-mRNA 竞争内源性 RNA 网络鉴定出四个 lncRNA 特征作为乳腺癌的预后生物标志物。
J Transl Med. 2018 Sep 27;16(1):264. doi: 10.1186/s12967-018-1640-2.
9
Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.乳腺癌中 DNA 甲基化的研究路线图确定了新的预后生物标志物。
BMC Cancer. 2019 Mar 12;19(1):219. doi: 10.1186/s12885-019-5403-0.
10
Analysis of KLF4 regulated genes in cancer cells reveals a role of DNA methylation in promoter- enhancer interactions.分析癌症细胞中 KLF4 调控的基因,揭示了 DNA 甲基化在启动子-增强子相互作用中的作用。
Epigenetics. 2018;13(7):751-768. doi: 10.1080/15592294.2018.1504592. Epub 2018 Aug 25.

引用本文的文献

1
Targeting Regulatory Noncoding RNAs in Human Cancer: The State of the Art in Clinical Trials.靶向人类癌症中的调控性非编码RNA:临床试验的现状
Pharmaceutics. 2025 Apr 4;17(4):471. doi: 10.3390/pharmaceutics17040471.

本文引用的文献

1
A novel arginine methylation-associated lncRNA signature effectively predicts prognosis in breast cancer patients.一种新型的精氨酸甲基化相关lncRNA特征可有效预测乳腺癌患者的预后。
Front Oncol. 2024 Oct 1;14:1472434. doi: 10.3389/fonc.2024.1472434. eCollection 2024.
2
CancerMHL: the database of integrating key DNA methylation, histone modifications and lncRNAs in cancer.癌症 MHL:整合癌症关键 DNA 甲基化、组蛋白修饰和长非编码 RNA 的数据库。
Database (Oxford). 2024 Apr 12;2024. doi: 10.1093/database/baae029.
3
The impact of DNA methylation on CTCF-mediated 3D genome organization.
DNA 甲基化对 CTCF 介导的三维基因组组织的影响。
Nat Struct Mol Biol. 2024 Mar;31(3):404-412. doi: 10.1038/s41594-024-01241-6. Epub 2024 Mar 18.
4
M6A RNA methylation modification and tumor immune microenvironment in lung adenocarcinoma.肺腺癌中的m6A RNA甲基化修饰与肿瘤免疫微环境
Biophys Rep. 2023 Jun 30;9(3):146-158. doi: 10.52601/bpr.2023.220020.
5
The risk model construction of the genes regulated by H3K36me3 and H3K79me2 in breast cancer.乳腺癌中受H3K36me3和H3K79me2调控基因的风险模型构建
Biophys Rep. 2023 Feb 28;9(1):45-56. doi: 10.52601/bpr.2023.220022.
6
LINC00536 knockdown inhibits breast cancer cells proliferation, invasion, and migration through regulation of the miR-4282/centromere protein F axis.LINC00536 敲低通过调控 miR-4282/着丝粒蛋白 F 轴抑制乳腺癌细胞的增殖、侵袭和迁移。
Kaohsiung J Med Sci. 2022 Nov;38(11):1037-1047. doi: 10.1002/kjm2.12583. Epub 2022 Sep 2.
7
ELOVL2-AS1 inhibits migration of triple negative breast cancer.ELOVL2-AS1 抑制三阴性乳腺癌的迁移。
PeerJ. 2022 Apr 14;10:e13264. doi: 10.7717/peerj.13264. eCollection 2022.
8
3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.与高危 T 系急性淋巴细胞白血病中 HOXA13 表达失调相关的 3D 基因组改变。
Nat Commun. 2021 Jun 17;12(1):3708. doi: 10.1038/s41467-021-24044-5.
9
The long non-coding RNA landscape in triple-negative breast cancer.三阴性乳腺癌中的长非编码 RNA 全景。
Cell Prolif. 2021 Feb;54(2):e12966. doi: 10.1111/cpr.12966. Epub 2020 Dec 13.
10
The roles of long noncoding RNAs in breast cancer metastasis.长非编码 RNA 在乳腺癌转移中的作用。
Cell Death Dis. 2020 Sep 14;11(9):749. doi: 10.1038/s41419-020-02954-4.